BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20260805T014327EDT-5931IlKkHK@132.216.98.100 DTSTAMP:20260805T054327Z DESCRIPTION:JEWISH GENERAL HOSPITAL\nDEPARTMENT OF MEDICINE\nMONDAY MEDICAL GRAND ROUNDS\nJUNE 2011\n12:30 - 1:30 P.M.\nBLOCK AMPHITHEATRE\n \nJUNE 6 \nOPPORTUNITY KNOCKS: EARLY PHYSIOTHERAPY AND SPONTANEOUS\nAWAKENING TRIAL S IN CRITICALLY ILL PATIENTS\nPresenter: Amjad Al-Rajhi\nThird Year Intern al Medicine Resident\n91Ë¿¹ÏÊÓÆµ & Jewish General Hospital\nSupervi sor: Denny Laporta\, MD\nAssistant Professor of Medicine\n91Ë¿¹ÏÊÓÆµ Universit y\nAdult Critical Care Unit\nPulmonary Division\nJewish General Hospital\n Educational Objectives:\n1. To describe a practice profile combining sedat ion\, analgesia\,\nand mobility surrogates in a cohort of critically ill I CU\npatients\n2. Identify opportunities and barriers to patient recovery f rom\ncritical illness in the ICU\nContact Person: Dr. M. Elizov\, Director \, Postgraduate Teaching\,\nTel. 514-340-8222 x 4974.\n\nJUNE 13\nERYTHROP OIETIN USE IN KIDNEY DISEASE:  INTENT TO\nTREAT\nGershon Frisch\, MD\nAssi stant Professor of Medicine\, 91Ë¿¹ÏÊÓÆµ\nDivision of Nephrology\, Jewish General Hospital\nEducational Objectives:\n1. Clinical use of Eryth ropoietin in patients with Kidney\ndisease\n2. Review of the key Erythropo ietin clinical outcome trials and\ntheir impact on current clinical practi ce\n3. Safety issues regarding Erythropoietin use in patients with\nKidney disease\nContact Person: Dr. Mark Lipman\, Chief\, Division of Nephrology \,\nTel. 514-340-8229.\n\nJUNE 20\nADVANCES IN THE TREATMENT OF PERITONEAL CARCINOMATOSIS:\nHYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)\nTsafr ir Vanounou\, MD\, MBA\, FRCSC\nAssistant Professor of Surgery\n91Ë¿¹ÏÊÓÆµ Uni versity\nSurgical Oncology\, HepatoBiliary Surgery\nJewish General Hospita l\nEducational Objectives:\n1.  Understand the indications and contra-indi cations for\nHIPEC\n2.  Understand the clinical advantage of HIPEC relativ e to\nother treatment options\n3.  Understand the technique as well as its associated\nmorbidity and mortality\nContact Person: Dr. L. Panasci\, Dep artment of Oncology\, Tel.\n514-340-8222 x 4915.\n\nThe Medical Grand Roun ds are an accredited group learning\nactivity as defined by the Maintenanc e of Certification Program of\nthe Royal College of Physicians and Surgeon s of Canada.\n DTSTART:20110602T163000Z DTEND:20110627T173000Z SUMMARY:JGH Monday Medical Grand Rounds - Month of June URL:/channels/event/jgh-monday-medical-grand-rounds-mo nth-june-174567 END:VEVENT END:VCALENDAR